本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corbus Pharmaceuticals Holdings, Inc.

8.08
-0.0400-0.49%
盤前8.00-0.0786-0.97%05:38 EDT
成交量:839.64萬
成交額:7,330.12萬
市值:1.56億
市盈率:-1.33
高:8.70
開:7.93
低:7.66
收:8.12
52周最高:20.56
52周最低:7.12
股本:1,934.13萬
流通股本:1,741.65萬
量比:8.17
換手率:48.21%
股息:- -
股息率:- -
每股收益(TTM):-6.0889
每股收益(LYR):-5.9000
淨資產收益率:-95.58%
總資產收益率:-53.00%
市淨率:1.53
市盈率(LYR):-1.37

資料載入中...

2022/04/11

重要事件披露

8-K - Current report
2022/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/08

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/03

重要事件披露

8-K - Current report
2021/12/08

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/12/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/24

重要事件披露

8-K - Current report
2021/06/17

重要事件披露

8-K - Current report
2021/06/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/01

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report